Interactions between human plasma proteins and heparin-poly(methyl methacrylate) copolymer

Area of Science:

• Biomaterials Science
• Polymer Chemistry
• Biochemistry

Background:

• Heparin-PMMA copolymers are investigated for biomedical applications due to heparin's anticoagulant properties and PMMA's biocompatibility.
• Understanding protein adsorption and clotting factor interactions is crucial for designing effective biomaterials.

Purpose of the Study:

• To synthesize and characterize a solid Heparin-PMMA copolymer.
• To investigate the protein adsorption behavior of the copolymer in the presence of plasma.
• To evaluate the effects of the Heparin-PMMA copolymer on plasma clotting factors.

Main Methods:

• Radical polymerization of methyl methacrylate initiated by Ce4+ ions in the presence of heparin.
• Protein adsorption and desorption studies using plasma.
• Assays to measure clotting factor activities (antithrombin III, factor V, factor XI, prekallikrein, factor IX).

Main Results:

• Covalently linked heparin constituted 10% of the copolymer by weight, with 1% antithrombin activity.
• PMMA sequences dominated adsorption of fibrinogen, immunoglobulins, transferrin, and albumin, with fibrinogen showing the highest affinity.
• Heparin moieties mediated antithrombin III adsorption and reduced factor V activity; PMMA sequences activated factor IX.

Conclusions:

• The Heparin-PMMA copolymer exhibits distinct protein adsorption profiles driven by PMMA, and specific interactions with clotting factors mediated by both heparin and PMMA components.
• The study highlights the dual role of PMMA and heparin in influencing biomaterial-plasma interactions and coagulation pathways.
• These findings are relevant for developing advanced heparinized biomaterials with tailored anticoagulant and hemocompatible properties.